Awards & Advancement

BRANY adds Olsen to ProtocolBuilder Team

Wednesday, August 12, 2015

The Biomedical Research Alliance of New York (BRANY), the developer of Protocol Builder, has appointed Christopher Olsen as senior director of national sales and marketing. Olsen will be responsible for sales and marketing efforts with academic medical centers, health systems, hospitals and individual clinical investigators.

[Read More]

Epizyme appoints Robert Bazemore president and CEO

Thursday, August 6, 2015

Epizyme, a clinical stage biopharmaceutical R&D company creating novel epigenetic therapeutics for cancer patients, has announced Robert Bazemore will succeed Robert Gould, Ph.D., as president and chief executive officer of Epizyme, effective Sept. 10. Bazemore also will join the Epizyme board of directors. Following the transition, Gould will continue to sit on the board and work as a consultant to the company.

[Read More]